Search results
FDA approves Alecensa as leading-edge adjuvant therapy for ALK-positive lung cancer
Clinical Trials Arena via Yahoo Finance· 4 days agoOn 18 April 2024, the US Food and Drug Administration (FDA) approved Roche’s Alecensa (alectinib),...
Why Nuvalent Stock Was Soaring Wednesday
Motley Fool· 7 months agoShares of Nuvalent (NASDAQ: NUVL) were up more than 27% as of 3:30 p.m. ET on Wednesday after the company reported preliminary phase 1/2 trial data for a...
Lung cancer blood tests that can speed up treatment offered to thousands of NHS patients
The Telegraph via Yahoo News· 1 month agoKat Robinson, diagnosed with stage 4 lung cancer in September, was quickly prescribed pills to "keep...
Waterfront Rescue Mission, Feeding the Gulf Coast among Rooted in Giving recipients
Pensacola News Journal via Yahoo News· 2 months agoFarm Credit of Northwest Florida recently announced a total of $18,500 awarded to five organizations...
